Sandoz Reports Commercial Availability Of Pyzchiva In The US - Quick Facts

(RTTNews) - Sandoz announced the launch of Pyzchiva, or ustekinumab-ttwe, in the US. The medicine is now commercially available to patients across the US. Developed by Samsung Bioepis Co., and commercialized by Sandoz, Pyzchiva has been approved by the FDA for the treatment of ce https://www.nasdaq.com/articles/sandoz-reports-commercial-availability-pyzchiva-us-quick-facts